Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis

Background and Purpose: The effect of Iguratimod in the treatment of rheumatoid arthritis was confirmed in past studies. In terms of the mechanism of the effect and clinical application experience, Iguratimod has a potential value in the treatment of spondyloarthritis (SpA). This study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Li, Kunpeng, Zhao, Zheng, Wang, Yanyan, Jin, Jingyu, Guo, Junhua, Zhang, Jie, Zhang, Jianglin, Zhu, Jian, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208078/
https://www.ncbi.nlm.nih.gov/pubmed/34150809
http://dx.doi.org/10.3389/fmed.2021.678864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208078/
https://www.ncbi.nlm.nih.gov/pubmed/34150809
http://dx.doi.org/10.3389/fmed.2021.678864

Ejemplares similares